Testing effectiveness (Phase 2)Looking for participantsNCT05616793
What this trial is testing
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
Who this might be right for
LCA5
Opus Genetics, Inc 22